专栏名称: Ben笔记
专注生物医药研究和行业动态,药路难,知难而上。初心贵,贵在坚持。苍生苦,济世悬壶。志须抒,更待何时。
今天看啥  ›  专栏  ›  Ben笔记

EAU 23

Ben笔记  · 公众号  ·  · 2023-03-14 21:24
    

文章预览

Progress and Controversies in Urologic Oncology @Silke_Gillessen summarizes where Lu-PSMA fits in the PCa treatment paradigm based on initial tx received in mHSPC disease setting ProtecT 15-yr PROs published overnight in NEJM Evidence: No diff in HRQoL Urine leakage (1+PPD): 24% in RP, 11% AM, 8% XRT Sexual function similar: 13% RP, 17% AM, 15% XRT Bowel function: 12% XRT vs 6% in RP/AM RenuEapen argues in favor of PSMA-PET/CT for AS PRIMARY: combined MRI+PET ️ missed csPCa from 17% to 3% ️SUVmax-->️GS ️PROMIS score associated with ️csPCa       ………………………………

原文地址:访问原文地址
快照地址: 访问文章快照
总结与预览地址:访问总结与预览